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1. Introduction 
 
 
 
The cornea is the transparent, with tear fluid moistened, frontal part of the eye that 
covers the iris, pupil and anterior chamber, providing most of an eye's optical 
refraction. The corneal tissue consists of five basic layers: the epithelium, Bowman’s 
lamella (anterior limiting membrane), the stroma, Descemet’s membrane (posterior 
limiting membrane) and the endothelium.  
Today, corneal transplantation (keratoplasty) is the most common form of tissue 
allotransplantation. The corneal graft rejection rate is low, therefore systemic 
immunosuppression is not routinely used and human leukocyte antigen (HLA) 
matching is rarely performed, except for high-risk cases. Graft failure occures mostly 
due to immune rejection. Thus, corneal transplants enjoys a considerable degree of 
immune privilege and immune rejection remains the leading barrier of long-term 
corneal graft survival. The cornea is a site devoid of a vascular network but the 
immune privilege of corneal allografts is not only based on the presence of an 
avascular graft bed. Furthermore, low rates of donor-specific Langerhans cells (LCs), 
Fas ligand expression, expression of complement regulatory proteins and 
immunmodulatory effects of the humoral components of the aqueous humour and the 
immune modulation (Anterior chamber associated immune deviation = ACAID) are 
involved in this complex reaction. For general purposes, high-risk corneal 
transplantation refers to inhospitable qualities of the recipient, such as inflammatory 
neovascularization or ocular surface inflammation which leads to a high risk of 
rejection for a graft. Immunology has long been focused on antigens and 
lymphocytes, but the mere presence of these two parties does not always lead to 
immunity. A third party, the antigenpresenting cell system (APCs) is the initiator and 
modulator of the immune response (1).  
APCs capture and process antigens for presentation to T-lymphocytes, and produce 
signals required for the proliferation and differentiation of lymphocytes. In general, 
APCs can be classified into professional (B cells, macrophages, dendritic cells and 
Langerhans cells) that are able to activate and induce clonal expansion of both naive 
and memory T-cells and nonprofessional types (mesenchymal cells, endothelial 
cells) that are competent to stimulate memory T-cells (1). Professional APCs are so 
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called because they generally have a high constitutive expression of major 
histocompatibility complex (MHC) class II antigen, as well as costimulatory 
molecules. APCs include a heterogeneous family of cells that are able to uptake and 
process both exogenous and endogenous antigens into 10-20-amino-acid peptides, 
and load them on to MHC molecules. They traffic into the lymph node where they 
present the foreign antigens in combination with MHC Class II molecules to the T 
helper cell T cell receptors. The most capable APCs in most tissues, mainly in skin, 
are dendritic cells (DCs) and LCs. In fact, these cells are also known to serve as the 
professional APCs of the cornea and ocular surface (2-6). 
In immune-privileged sites, like the cornea, the process of immune activation is 
regulated by interfering with the maturation of the DCs and by altering the indigenous 
APCs toward the induction of tolerance. The primary function of dendritic cells is to 
capture and present protein antigens to naive T-lymphocytes located in the cortex of 
the lymph nodes. 
One milestone was the detection of conspicious dendritically shaped cells in the 
human epidermis by Paul Langerhans 1868 and these cells were named after him. 
He found them by using gold cloride impregnation technique, a method for nerve cell 
identification. This is why they were believed to be of nervous origin at that time (7). 
However, another decade past until LCs were definitively recognized as a member of 
the DC system. However, it took another 12 years until LCs were definitively 
recognized as a member of the DC system. Gerold Schuler and Ralph Steinman 
mainly contributed to this milestone by several observations in 1985. Schuler and 
Steinman recognized that Langerhans cells are a special form of DCs, and that they 
occur in distinct states of maturation (i.e. the ‘Langerhans cell paradigm’) that are 
characterized by reciprocally expressed antigen processing and T-cell stimulatory 
capacities (8, 9). The 1985 breakthrough was important but not the end of LC 
research.  
By the time electronmicroscopical analysis were possible tennis racket-like Birbeck 
granules were found in LCs and so these cells were associated with the immune 
system. There is strong evidence that Birbeck granules, in particular their main 
molecular constituent, i.e. the Langerin molecule, a mannose-specific C-type lectin, 
play a role in the endocytosis pathway (10). The Birbeck granules became a marker 
for Langerhans cells, especially for those in situ and in an immature state (7). LCs 
stem from bone-marrow cells of the myeloid lineage. Their precursors populate the 
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epidermis during fetal and early postnatal life where they gain their immunological 
function. They start expressing molecules like MHC class II and Langerin/CD207 (7). 
LCs are specialized to stimulate resting T cells and so they induce primary T cell 
immune responses. Thus, LCs play an important role in contact hypersensitivity, 
transplant rejection and other immunological processes.  
Corneal LCs, similar to skin LCs, are bone-marrow-derived cells that represent the 
professional APCs of the ocular surface. Constitutive expression of major 
histocompatibility complex (MHC) class II antigens is a characteristic feature of DCs 
(including LCs) in the corneal epithelium. MHC antigens are important components in 
both the generation and expression of immune response. They are cell surface 
proteins classified as class I (also termed human leucocytic antigen [HLA] A, B and 
C), found on all nucleated cells and class II (termed HLA, DP, DQ and DR), found on 
all APCs. MHC molecules are the sine qua non of T cell induced immunity. Clinically, 
there is a strong association between HLA and certain systemic and ocular diseases. 
Hamrah et al. demonstrated the phenotype and distribution of MHC class II negative 
LCs in the murine corneal epithelium. They showed that LCs became activated in 
inflamed cornea by upregulation of MHC Class II antigen and costimulatory 
molecules like CD80 and CD86 (4). Furthermore they found that there are at least 
three bone marrow-derived subsets in the normal corneal stroma in addition to the 
corneal LCs (3). The markers on APCs vary in their expression of surface markers 
(11). During the last years new surface markers  were established to characterize 
APCs especially in the human skin in more detail: Langerin (CD207), DC-SIGN 
(CD209) or DC-LAMP (CD208).  
After activation, DCs and LCs must still undergo further changes for migrating to 
lymph nodes. This involves down-regulation of E-cadherin (12) and an upregulation 
of adhesion molecules, such as alpha-6-beta-1-Integrin (13) and CD44 (14) and the 
induction of matrix metalloproteinase-9 (15). Another important role to achieve 
migration capabilities is the de novo expression of CCR7 (chemotactic cytokines 
Receptor 7) (16). Both CCR7 ligands, CCL19 (also known as macrophage 
inflammatory protein 3-, MIP-3), and CCL21 (also known as secondary lymphoid 
tissue chemokine, SLC), are expressed in the T-cell zones of secondary lymphoid 
organs. Therefore, CCR7-mediated DCs migration, guided by CCL19 and CCL21, 
results in accumulation of mature DCs in the afferent lymphatics and the T-cell areas 
of draining lymph nodes. Studies in CCR7-deficient mice have revealed a marked 
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defect in DC migration to lymph nodes and impaired primary immune  (17, 18). 
DCs and LCs are the most important cells concerning immunogenicity of the cornea 
and are important for the faith of a corneal graft. Our aim was to characterize human 
corneal dendritic cells including Langerhans cells in freshly isolated corneas as well 
as in long-term cultured ones by using immunofluorescent staining methods with new 
cell surface markers, which are already approved in human skin (publication 1). 
Cryosections and epithelial sheets were obtained and novel cell surface markers like 
Langerin (CD207), CD1a and DC-SIGN (CD209) were applied to determine the cell 
type and distinguish between epithelial Langerhans cells and interstitial type dendritic 
cells. DC-LAMP (CD208) served as marker for the maturation state of DCs. We were 
interested how long DCs and LCs were detectable in corneas cultured for different 
time periods in comparison to fresh corneas. We further wanted to know, if these 
cells migrate during culture into the culture medium and if so, how fast this emigration 
of APCs does occur. The rejection rate of corneal transplants is very small, and less 
APCs remain in the donor cornea. We therefore investigated in a second work 
(publication 2) whether the migration of DCs, LCs and macrophages from cultured 
human corneas into organ culture medium can be accelerate by the addition of 
chemotactically active substances. 
 
I contribute to these two manuscripts as a first author and was actively involved in all 
processes concerning literature review, establishing material and methods, 
performing observations, statistical analyses and writing. 
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3. Summary 
 
German: 
Einleitung:  
Antigenpräsentierende Zellen (APCs) spielen eine große Rolle für das Schicksal 
eines Hornhauttransplantates. In dieser Arbeit wurde die genaue Verteilung und 
Menge der APCs in der normalen frischen menschlichen Hornhaut untersucht. Dazu 
wurden neue Marker verwendet und mit bisher in der Hornhaut etablierten Markern 
verglichen. Die Abstoßungsrate von Hornhauttransplantaten ist umso geringer, je 
weniger APCs in der Spenderhornhaut verbleiben. Hier untersuchten wir auch, ob 
man die Migration von dendritischen Zellen (DCs), Langerhanszellen (LCs) und 
Makrophagen aus kultivierten Hornhäuten in ein Kulturmedium durch die Zugabe von 
chemotaktisch wirksamen Stoffen beschleunigen kann.  
Material/Methoden:  
Es wurden Gefrierschnitte sowie sogenannte „Epithelial Sheets“ angefertigt. Diese 
Präparate wurden anschließend mit einer Immunfluoreszenzdoppelfärbung in 
Dreistufentechnik gefärbt. Neue Marker (Langerin, CD1a, DC-SIGN und DC-LAMP) 
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wurden mit etablierten Markern verglichen. Humane Hautpräparate dienten als 
Positivkontrollen. Bei den Auswanderungsversuchen wurden die ins Kulturmedium 
migrierten Zellen nach 3, 7, 10, 14, 21, 28 und 35 Tagen gesammelt, und ein 
Zytospinpräparat angefertigt. Die Hornhäute wurden immer mit einer 
chemotaktischen Substanz inkubiert (CCL19, CCL21 oder C5a), Negativkontrollen 
nur mit Kulturmedium. Alle Präparate wurden mit einer Immunfluoreszenzfärbung in 
Dreistufentechnik gefärbt, entweder mit Langerin – HLA-DR (LCs), DC-SIGN – HLA-
DR (DCs), oder mit CD14 – HLA-DR (Monozyten/Makrophagen). Diese Präparate 
wurden anschließend ausgezählt und die Menge der migrierten Zellen miteinander 
verglichen. 
Ergebnisse:  
LCs (Langerin+CD1a+CD11c+HLA-DR+CD45+) konnten in der frischen 
menschlichen Hornhaut im Epithel und subepithelial gefunden werden, vor allem in 
der Peripherie und im Limbusbereich. Auch parazentral konnten wir noch einige 
dieser Zellen finden, wohingegen im Zentrum keine Langerin+CD1a+ LCs mehr 
nachweisbar waren. Nur wenige dieser Zellen in der Peripherie waren DC-LAMP+, 
was sie als reife Zellen auszeichnet. Im Stroma fanden wir DC-SIGN+ DCs (meist 
HLA-DR- und CD11c-, alle CD45+). 
Die meisten waren im anterioren Stroma der Peripherie und im Limbusbereich 
lokalisiert, aber auch parazentral und zentral konnten einige DC-SIGN+ DCs 
beobachtet werden. Wenige DCs in der Peripherie waren auch DC-LAMP+(reife 
DCs). Eine zweite Population DCs (DC-SIGN-CD11c+HLA-DR+) konnte im 
gesamten Stroma gefunden werden. Im posterioren Stroma konnten CD11c-CD11b+ 
Makrophagen und CD14+ Zellen lokalisiert werden. 
In den Auswanderungsversuchen konnte gezeigt werden, dass sowohl LCs, als auch 
DCs und Makrophagen in Organkultur aus der Hornhaut in das Kulturmedium 
migrieren. Es konnte auch gezeigt werden, dass in der normalen frischen 
menschlichen Hornhaut CCR7+ Zellen lokalisiert sind. Hier konnte durch die Zugabe 
des CCR7-Liganden CCL19 eine vermehrte LCs Auswanderung in das Medium 
beobachtet werden. Auch DC-SIGN+ DCs konnten nach Zugabe von CCL19 oder 
CCL21 vermehrt im Medium gefunden werden, wohingegen eine Wirkung dieser 
Chemokine auf CD14+ Zellen nicht nachgewiesen werden konnte. 
Danach konnte kein Unterschied mehr zu den Negativkontrollen festgestellt werden.  
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Conclusio:  
In diesen Arbeiten konnte gezeigt werden, dass in der frischen menschlichen 
Hornhaut eine Vielzahl von APCs lokalisiert sind, welche einen Risikofaktor für eine 
Transplantatabstoßung darstellen. Es konnte außerdem gezeigt werden, dass es 
während der Organkultur zu einer Migration von APCs in das Kulturmedium kommt 
und diese Migration durch eine Vielzahl von Chemokinen geregelt wird. 
 
English: 
Background:  
Antigen presenting cells (APCs) are responsible for the faith of corneal grafts. In this 
study we investigated the density and distribution of Langerhans cells (LCs), dendritic 
cells (DCs) and macrophages using novel markers. Furthermore we investigated the 
migration of APCs to the culture-medium during organ culture. 
Methods:  
Epithelial flat mounts and whole stromal cryosections were stained with 
immunofluorescence double staining triple layer technique. The following antibodies 
were used: Langerin/CD207, CD1a, DC-SIGN/CD209, CD11c, CD11b, CD45, DC-
LAMP/CD208 and HLA-DR. Human skin was used for positive control. In the 
migration assay the cells were collected every 3, 7, 10, 14, 21, 28 and 35 days and a 
cytospin-slide was prepared. Corneas were incubated with an chemotactic substance 
(CCL19, CCL21 or C5a), negativ controls only with culture medium. 
Results:  
LCs (Langerin+CD1a+CD11c+HLA-DR+CD45+) were detected in the epithelium and 
subepithelial, mainly in the periphery and limbal part. Towards the corneal center a 
significant decrease of these cells was observed. Few LCs co-expressed DC-LAMP 
in the peripheral epithelium thus indicating mature LCs. In the stroma we found three 
populations of cells: DC-SIGN-positve DCs (most of them HLA-DR and CD11c-
negative, all CD45+), most of them in the periphery, a few also paracentral in the 
central corneal part. Few of them in the peripheral stroma co-expressed DC-LAMP. 
The second population were DC-SIGN-negative, CD11c+CD45+HLA-DR+ DCs. We 
found a substantial number of these cells in the whole stroma. Furthermore 
macrophages (CD11c-CD11b+ / CD14+) were detectable. They were mainly located 
in the posterior peripheral stroma. We could also observe cells expressing the CCR7-
antigen in the normal fresh human cornea. Furthermore, an increased migration rate 
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of LCs and DCs could be investigated by the addition of its ligands CCL19 and 
CCL21 to the culture-medium. No effect of these chemokines to CD14+ 
macrophages could be shown.  
Conclusion:  
These studies demonstrates the exact density and distribution of several APCs in the 
human cornea, in comparison to the human skin, using novel antibodies. 
Furthermore migration capabilities of APCs into the culture medium during organ 
culture incubation could be demonstrated and is modulated by a multitude of 
chemokines.   
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Characterization of Antigen-Presenting Cells in Fresh
and Cultured Human Corneas Using Novel Dendritic
Cell Markers
Wolfgang J. Mayer,1,2 Ulrike M. Irschick,1 Patrizia Moser,3 Martin Wurm,4
Hartwig P. Huemer,5 Nikolaus Romani,6 and Eveline U. Irschick1
PURPOSE. Adult healthy human corneas bear a distinctive num-
ber of antigen-presenting cells (APCs) important for the fate of
a graft. The purpose of this study was to differentiate between
Langerhans cells (LCs) and other dendritic cells (DCs) and
between mature and immature APCs in fresh and cultured
human corneas using specific markers.
METHODS. Immunofluorescence double staining was performed
for Langerin/CD207, CD1a, DC-SIGN/CD209, DC-LAMP/
CD208, CD45, CD11c, CD11b and HLA-DR.
RESULTS. Langerin/CD1a/HLA-DR LCs (approximately 100
cells/mm2 in fresh corneas) were found in the limbal and
peripheral regions of corneal epithelium and the anterior
stroma up to 83 days of culture. All these cells coexpressed
CD45 and CD11c. DC-SIGN/CD45 DCs (approximately 150
cells/mm2 in fresh corneas) were detected mainly peripherally
and in the anterior stroma, even in long-term cultured corneas.
Most of these cells were HLA-DR. Few mature DCs (DC-
LAMP/HLA-DR) were found in fresh and cultured corneas.
Macrophages (CD11c/CD11b) were seen in the peripheral,
paracentral, and even central regions of the posterior stroma.
CONCLUSIONS. This is the first demonstration that human cor-
neas harbor populations of Langerin/CD1a/HLA-DR LCs
and DC-SIGN DCs in a distribution pattern similar to that in
the skin. Few APCs are in a mature state (DC-LAMP). Given
the reduced but not complete depletion of APCs during
organ culture, these grafts still bear a potential risk for
rejection. (Invest Ophthalmol Vis Sci. 2007;48:4459 – 4467)
DOI:10.1167/iovs.06-1184
The most capable antigen-presenting cells (APCs) in severaltissues, primarily skin, are dendritic cells (DCs), including
Langerhans cells (LCs). Besides macrophages, these cells func-
tion as professional APCs of the cornea and ocular surface.1–5
They serve as immune “sentinels” against a foreign world. With
the use of standard markers, different maturation stages of DC
subsets are detectable at various corneal sites. These DCs have
the capacity to determine the outcome of immunity or toler-
ance within this organ.6
Through electron microscopy, tennis racket-like Birbeck
granules were found in LCs. Strong evidence indicates that
Birbeck granules, particularly their main molecular constitu-
ent—the Langerin molecule, a mannose-specific C-type lec-
tin—plays a role in the endocytosis pathway.7 Birbeck granules
become reliable markers for Langerhans cells, especially for
immature cells.8
In human skin, LCs constitute approximately 2% to 4% of all
epidermal cells.9 They are the epidermal variant of DCs and are
uniformly distributed (approximately 700 cells/mm2). LCs
stem from bone marrow cells of the myeloid lineage. Their
precursors populate the epidermis during fetal and early post-
natal life, when they gain their immunologic function. They
start expressing molecules such as major histocompatibility
complex (MHC) class II, Langerin/CD207, and DEC-205/
CD205.8 LCs are specialized to stimulate resting T cells and to
induce primary T-cell immune responses. Thus, LCs play im-
portant roles in contact hypersensitivity, transplant rejection,
and other immunologic processes.
Corneal LCs, similar to skin LCs, are bone-marrow-derived
cells that represent the professional APCs of the ocular surface.
It had been thought that constitutive expression of MHC class
II antigens is a characteristic feature of DCs (including LCs) in
the corneal epithelium. Under nonpathologic circumstances,
LCs are the only cells that constitutively express MHC class II
molecules in the corneal epithelium.10 MHC antigens are im-
portant components in the generation and the maintenance of
immune responses. However, a recent study by Hamrah et al.3
demonstrated that an MHC class II LC population exists in the
murine corneal epithelium. The authors showed that LCs be-
came activated in inflamed corneas by the upregulation of
MHC class II antigens and costimulatory molecules such as
CD80 and CD86.3 Furthermore, they found at least three bone-
marrow-derived subsets of DCs in the normal corneal stroma in
addition to the corneal LCs.2 Thus, APCs vary in their expres-
sion of surface markers.6,11
Langerin/CD207 is selectively expressed by LCs,7,12 CD1a
on cortical thymocytes, dendritic cells, and LCs, especially in
skin. LCs express comparatively high levels of CD1a and Lan-
gerin, which imparts a unique functional role to these cells in
initiating immune responses to microbial pathogens.13 DC-
SIGN/CD209 is a type 2 transmembrane protein that also con-
tains a mannose-binding (C-type lectin) domain. It is not ex-
pressed on LCs14–16 but is expressed on dermal DCs.17 CD208/
DC-LAMP is a member of the lysosome-associated membrane
glycoprotein (LAMP) family.18 DC-LAMP is specifically ex-
pressed by mature dendritic cells located in the T-cell areas of
lymphoid tissues, which are known as interdigitating dendritic
cells.18–20 Mature skin LCs also express DC-LAMP.17 A direct
correlation between the expression of DC-LAMP and that of
other maturation markers, such as CD86, has been established
in skin.18
DCs and LCs are the most important cells regulating immu-
nogenicity of the cornea and are important for the reliability of
a corneal graft. The aim of this study was to characterize
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human corneal dendritic cells, including LCs, in freshly isolated
corneas and in long-term cultured corneas by using immuno-
fluorescence staining with specific markers applied to human
skin but hitherto not yet to the human cornea. Langerin,
DC-SIGN, and CD1a were used to determine cell type and to
distinguish between epidermal–epithelial Langerhans cells and
dermal–interstitial dendritic cells. Costaining with antibodies
against CD45, CD11c, and CD11b was performed to validate
and extend our observations. Additionally, we screened the
corneas for macrophages (i.e., CD11c/CD11b cells). Fur-
thermore, DC-LAMP served as a marker for the maturation state
of dendritic cells. We examined the horizontal and vertical DC
distribution in comparison with human skin and were inter-
ested in determining how long DCs and LCs were detectable in
corneas cultured for different time periods compared with
fresh corneas. We also investigated whether the routinely per-
formed decontamination step for preparing donor corneas had
an influence on DCs and LCs, and we compared the densities
of LCs and DCs in young and elder corneas.
MATERIALS AND METHODS
Preparation and Culture of Human Corneas
This research was approved by the Department of Ophthalmology at
Innsbruck Medical University and adhered to the tenets of the Decla-
ration of Helsinki. Human corneas were primarily enucleated for trans-
plantation purposes. Excluded corneas were used for our study. After
enucleation, the eyes were dissected under the guidelines for Austrian
eye banks. In total, 47 corneas were available from 24 male and 23
female donors ranging in age from 20 to 96 years (median, 63 years).
Nine fresh corneas were used. The other corneas were cultured and
grouped according to the duration of culture (9 corneas up to day 21,
29 corneas from day 22 to day 1076).
Preparation was performed as recently described.21 In brief, bulbi
were cleared from remainders of the conjunctiva and eye muscles.
They were washed for 5 minutes with floating tap water, decontami-
nated with povidone iodine (Polyvidon-Jod 0.5%; Betaisodona; Mun-
dipharma, Limburg/Lahn, Germany) for 2 minutes, discolored with
sodium-thiosulfate (0.1%) for 1 minute (Gatt-Koller, Absam, Austria),
and rinsed with PBS (PAA Laboratories, Pasching, Austria). To evaluate
the influence of the decontamination procedure on the LCs and DCs,
five corneas were used without decontamination. Further processing
occurred under sterile conditions. The isolated corneas were washed
with PBS and placed into sterile tubes (Sarstedt, Nümbrecht, Germany)
containing 25 mL culture medium RPMI 1640 (with 2.0 g/L NaHCO3,
without phenol red and without L-glutamine [Biochrome AG, Berlin,
Germany]) supplemented with 100 U/mL penicillin G, 100 g/mL
streptomycin, 0.25 g/mL amphotericin B (Gibco/Invitrogen Corp.,
Grand Island NY), 2 mM L-glutamine (Low Endotoxine; Biochrome), 25
mM HEPES-buffer (Biochrome), and 5% fetal calf serum (Gibco/Invitro-
gen). With the use of a long-term culture medium, it is possible to
culture human corneas at 31°C for long periods by renewing the
medium every week. Cell viability after long-term culture was moni-
tored with trypan blue (Sigma Chemical, St. Louis, MO) staining tech-
nique. Even after the longest observation period (more than 1000
days), epithelial cells were still viable.
Cryosections were obtained using a microtome (CM-3050; Leica-
Microsystems, Wetzlar, Germany). Deep-frozen tissue was embedded
in OCT compound medium (Tissue-Tek; Sanova, Vienna, Austria).
Before cryosectioning, the human corneas were divided into central
parts (diameter, 3 mm) and peripheral areas (adjacent to the central
parts reaching the limbus). Human skin samples served as positive
controls. Sections (8 m) were cut at 26°C, allowed to dry at room
temperature for 1 hour, and stored at 20°C.
Fresh corneas were used to obtain epithelial flat mounts and whole
stromal cryosections. They were immersed in PBS containing 20 mM
EDTA (Sigma-Aldrich) at 37°C for 1 hour. The epithelium was sepa-
rated from the stroma with small tweezers and was washed again in
PBS. Epithelial sheets were put on slides and fixed in acetone for 15
minutes at room temperature. Consecutive cryosections (10-m thick-
ness) were obtained from the whole corneal stroma.
Immunoreagents
The following unconjugated primary mouse antibodies were used at
the indicated final concentrations: anti–CD207/Langerin (clone
DCGM4, IgG1, 2 g/mL; Beckman Coulter, Fullerton, CA), anti–CD1a
(clone HI149, IgG1, 3.125 g/mL; BD Biosciences, Franklin Lakes, NJ),
anti–CD209/DC-SIGN (clone DCN46, IgG2b, 5 g/mL; BD Bio-
sciences), anti–CD208/DC-LAMP (clone 104.G4, IgG1, 2 g/mL; Beck-
man Coulter), and anti–CD11c (clone B-ly6, IgG1, 10 g/mL; BD
Biosciences). As tertiary mouse antibodies, the following were used in
an immunofluorescent double-staining technique: FITC-conjugated
anti–HLA-DR (clone L243, IgG2a, 2.5 g/mL; BD Biosciences), FITC-
anti–CD45 (clone HI30, IgG1, 10 g/mL; BD Biosciences), FITC-anti–
CD1a (clone HI149, IgG1, 10 g/mL; BD Biosciences), FITC-anti–
CD11c (clone BU15, IgG1, 5 g/mL; Serotec Ltd., Kidlington, Oxford,
UK), FITC-anti–CD11b (clone ICRF44, IgG1, 5 g/mL; Serotec), Alexa-
488-conjugated anti–CD208/DC-LAMP (clone 104G4, IgG1, 50 g/mL;
Dendritics, Dardilly, France), FITC-anti–CD86 (clone 2331, IgG1, 4
g/mL; BD Biosciences), and FITC-anti–CD80 (clone L307.4, IgG1, 8
g/mL; BD Biosciences).
Immunofluorescent Double Labeling in Triple-
Layer Technique
A biotin-streptavidin–based triple-layer technique was used. Sections
and sheets were first incubated with primary unconjugated antibodies
(all diluted in PBS/1% bovine serum albumin, 30 minutes, 37°C). After
thorough washing (5 minutes in PBS/1% BSA), the biotinylated second-
ary antibody (sheep anti–mouse immunoglobulin, dilution of 1:100;
Amersham Pharmacia Biotech, Buckinghamshire, UK) was applied (30
minutes, 37°C). In the third step, Texas Red-conjugated streptavidin
was applied (Amersham; 1:100, 30 minutes, 37°C). Then a blocking
reagent (mouse -globulin, final concentration 100 g/mL; Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA) was used to
avoid binding of the subsequent FITC-conjugated antibody to residual
free binding sites of the preceding anti–mouse immunoglobulin anti-
body. Finally, the FITC-conjugated antibody was applied (30 minutes,
37°C), and the tissue sections were covered with fluorescent mounting
medium (Vectashield; Vector Laboratories, Burlingame, CA).
An optical microscope (DMLB; Leica) and a digital microscope
(DM6000B; Leica) were used for analysis and to obtain digital pictures.
Because of the low density of LCs and DCs in the cornea, especially in
long-term cultured corneas, it was necessary to evaluate a large number
of corneal sections. Each section was inspected over its entire length
using total magnifications of 200, 400, and 630 (DM6000B; Leica)
and 100 and 400 (DMLB; Leica), and the expression of all used
markers was recorded.
With the use of a software-controlled scanning grid (PicED Cora;
Jomesa Messsysteme GmbH, Munich, Germany), it was possible to
enumerate the cells in the different areas of the cornea. Six to eight
different fields were analyzed for each specimen, and the numbers
were averaged. For analytical purposes, the cornea was divided into
different areas. The central area measured 3 mm in diameter. The
paracentral region constituted the area between 3 and 4 mm around
the center, and the peripheral rim reached from the paracenter to the
limbus. Results were compared with observations found in human
skin. Human foreskin served as a positive control because this tissue
bears a high density of Langerhans and dermal dendritic cells. The
following mouse antibodies were used as negative controls: IgG1
(clone DAK-G01, IgG1; DAKO A/S, Glostrup, Denmark), IgG2b (clone
DAK-G09, IgG2b; DAKO), FITC-conjugated IgG2a (clone RPC5,
IgG2a; Hölzel Diagnostika, Köln, Germany), and FITC-conjugated IgG1
(clone MOPC-21, IgG1; BD Biosciences). We did not find any unspe-
cific binding of control immunoglobulins (Fig. 1).
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Statistical Analysis
Student’s t-test was used to compare the number of positively labeled
epithelial and stromal cells in different areas of fresh and cultured
corneas. P  0.05 was considered significant.
RESULTS
Expression of CD207/Langerin
Langerin discriminates between LCs and other DCs and
thereby specifically identifies LCs. Corneal LCs (Langerin
cells) were primarily found in fresh corneas (Figs. 2, 3). Most of
them were large cells and showed classic dendritic morphol-
ogy with long dendrites. Their localization was mainly in the
peripheral epithelium of the cornea, but they were also found
within the limbus (Fig. 4). Toward the center of the cornea, the
number of LCs strongly decreased. Few Langerin LCs were
found in the paracentral area of the cornea (diameter, 3–4
mm). No Langerin cells were found in the centers of any of
the tested corneas (Figs. 3–5).
Double staining with MHC class II antibody showed strong
coexpression in all Langerin LCs (Fig. 2A). In addition, all the
Langerin cells coexpressed CD45 (indicating bone-marrow
derivation) and CD11c (indicating DC lineage). In the periph-
eral part of the cornea, few were positive for DC-LAMP; thus,
they represented mature LCs.
Double labeling of human epidermis with Langerin and
CD1a showed that virtually all Langerin cells were
CD1a.12,17 This was also seen in fresh corneas.
Langerin LCs were also found in long-term cultured cor-
neas. The longer the culture, the fewer Langerin LCs devel-
oped. We detected LCs consistently in corneas cultured up to
56 days and in some cultured for up to 3 months (Figs. 2B, 5).
After approximately 80 days of culture, Langerin cells were
no longer found. This reduction in Langerin LCs was statisti-
cally significant (P  0.05) during the first 21 days of culture.
Expression of CD1a
We found CD1a cells in fresh corneas in the limbal and
peripheral regions (Fig. 6A). These cells were never found in
central areas of all examined corneas, and few were located in
the paracentral region (Figs. 3, 4). CD1a cells were also
detectable in cultured corneas until approximately 80 days
(Figs. 5, 6B). In contrast to Langerin, CD1a was expressed at
lower levels of fluorescence intensity in fresh and in long-term
cultured corneas (Figs. 2A, 2B). As in Langerin cells, CD1a
cells were statistically significantly reduced during the first 21
days of culture (P  0.05; Fig. 5A). Double-labeling experi-
ments revealed that most, if not all, LCs coexpressed Langerin
and CD1a. Langerin and CD1a cells were double stained
with antibodies against HLA-DR, CD45, and CD11c, and there
was virtually 100% overlap. Few CD1a cells in the peripheral
epithelium were also positive for DC-LAMP and thus qualified
as mature LCs.
Expression of CD209/DC-SIGN
In the skin, DC-SIGN is expressed on dermal DCs but not on
LCs. In the cornea, DC-SIGN cells were found only in the
stroma, never in the epithelium (Fig. 7A). This observation is
comparable to that in the skin, where DC-SIGN cells are also
found exclusively in the dermis (Fig. 7C). All DC-SIGN coex-
pressed CD45, but only some (approximately 12%) coex-
pressed CD11c. Their density in the stroma was statistically
significantly higher than Langerin cells in the epithelium (P 
0.05; Figs. 3, 5).
In fresh and in cultured corneas, there was a pronounced
accumulation of DC-SIGN cells in the limbal and peripheral
regions (Figs. 3, 5, 7A, 7B). They were predominantly localized
in the anterior corneal stroma and were distributed more
toward the center than were Langerin cells (Figs. 3, 4). We
found a statistically significant reduction during the first 21
days of culture (P  0.05). Most DC-SIGN cells did not
FIGURE 1. (A) Negative control for
immunoglobulin class IgG1. (B) Neg-
ative control for immunoglobulin
class IgG2b. Note that IgG2a is in-
cluded in the double-staining proce-
dure. (A, B) Magnification, 200.
FIGURE 2. Langerin cells in human corneas. (A) Fresh double-stained cornea with markers for Langerin (red) and HLA-DR (green). LCs are located
in the epithelium and anterior stroma (arrows) and show expression of both markers. (B) Cultured cornea (56 days) stained with the same markers
(arrows). (C) Human skin, which served as a positive control. LCs are located in the epidermis (arrows). Magnifications, (A) 630, (B) 400, (C)
200.
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express MHC class II; in those that did, the expression was
below the threshold of detection (Fig. 4). Inversely, we ob-
served substantial numbers of DC-SIGN but MHC class II
cells in the periphery and in the central parts of the stroma.
Few DC-SIGN cells (approximately 6%) coexpressed DC-
LAMP in the peripheral stroma, thus indicating mature DCs.
FIGURE 3. Densities of APCs (cells/mm2) in fresh human corneas (n  9). APC densities in the peripheral, paracentral, and central areas of (A)
epithelium and (B) stroma.
FIGURE 4. APCs within the whole
fresh cornea. (A) Distribution of APCs
within the central, paracentral, and pe-
ripheral regions of the human cornea.
(B) Distribution of APCs within the
corneal layers. All APCs were positive
for CD45. Langerin, CD1a, and HLA-
DR (LCs) are located in the periph-
eral regions of the corneal epithelium.
LCs were also positive for CD11c. HLA-
DR/CD11c cells (yellow) were
present in the paracentral and central
corneal epithelium. DC-SIGN/HLA-
DR cells (DCs) are located in the pe-
ripheral, paracentral, and even central
anterior stroma. Few were positive for
HLA-DR. They showed higher density
than LCs. DC-SIGN cells only partially
overlapped with CD11c. Other HLA-
DR– expressing cells (blue) were
found in the whole cornea, primarily
in the anterior stroma. DC-LAMP and
HLA-DR cells (mature DCs) are rare
and are located only in the limbal and
peripheral stroma/epithelium of the
cornea. Macrophages (CD11c/
CD11b) are located in the peripheral,
paracentral, and central part of the
posterior stroma.
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Expression of CD208/DC-LAMP
As best illustrated in human skin, numbers of DC-LAMP–ex-
pressing DC are always much lower than numbers of MHC
class II–expressing cells.17 Similarly, few DC-LAMP cells were
found in fresh or in cultured corneas (Figs. 8A, 8B). DC-LAMP
cells were rare in the epithelium, where LCs reside (Figs. 3–5).
Rather they were invariably Langerin and thus qualified as
scarce, mature LCs. In the stromal layer, DC-LAMP cells were
located only in the periphery, preferentially in the anterior
stroma but never in the center. Costaining with CD45, HLA-DR,
and CD11c showed that all DC-LAMP cells were positive for
FIGURE 5. Kinetics of LC/DC reduction (cells/mm2) during long-term culture. LC/DC densities in the peripheral, paracentral, and central area of
the human corneal epithelium (A) and stroma (B).
FIGURE 6. CD1a staining of human corneas. (A) Fresh double-stained cornea with markers for CD1a (red) and HLA-DR (green). LCs are located
in the epithelium and anterior stroma (arrows), primarily in the periphery, and show expression of both markers. (B) Cultured cornea (culture
period, 21 days) stained with the same markers (arrows). (C) Human skin as positive control. In skin, LCs are located in the epidermis (arrows).
Magnification, 400 (A–C).
IOVS, October 2007, Vol. 48, No. 10 APCs in Fresh and Cultured Human Corneas 4463
CD45 and HLA-DR but that only some were positive for CD11c.
DC-LAMP mature DCs were only partially DC-SIGN, imply-
ing that the peripheral stroma harbors two sets of rare mature
DCs, those that coexpress DC-SIGN (mostly CD11c) and
those that do not coexpress DC-SIGN (CD11c). Given that
multicolor immunofluorescence analyses could not be per-
formed, these cells were not characterized further. In addition,
costaining with CD86 showed that approximately two thirds of
the stromal DC-LAMP cells were also positive for CD86. In
accordance with previous findings,22–24 the expression level of
CD80 was extremely low in human DCs; therefore, no com-
parisons could be made (data not shown).
DC-LAMP was detectable in cultured corneas for more than
60 days (Fig. 8B). Although the total number of DC-LAMP
cells decreased during long-term culture, some in situ matura-
tion of DCs in culture still occurred, as reflected by the peak on
day 56 (Fig. 5B).
Macrophages
We found cells expressing a phenotype compatible with mac-
rophages (CD11c/CD11b) only in the posterior part of the
corneal stroma. They were located in the peripheral, paracen-
tral, and even in the central regions (Figs. 3, 4). No CD11c/
CD11b cells were found in the epithelium of the cornea. All
macrophages were positive for CD45. They did not express
Langerin, CD1a, DC-SIGN, or DC-LAMP, as deduced from the
observation that none of these molecules was ever found in
that location of the stroma.
Comparison of corneas from young and elder donors re-
vealed no difference in the distribution of LCs and DCs. We
also noted that the decontamination step with an iodine-con-
taining solution did not change the distribution or density of
the APCs of the human cornea (data not shown).
DISCUSSION
Corneal grafts were initially thought to be almost devoid of
donor-derived APCs.5,25 The presence of corneal APCs was
described more than 15 years ago.10 Their exact characteriza-
tion and localization, however, are still being discussed.26,27
For instance, LCs were often defined on the mere basis of their
epidermal/epithelial location. Therefore, we reinvestigated this
issue with novel, dendritic cell subset-specific antibodies that
were already extensively used in human skin.17,28 It was pos-
sible, then, to identify and mutually discriminate between LCs
by using Langerin or CD1a and interstitial DCs by using DC-
SIGN. Given that Langerin and DC-SIGN are c-type lectins that
may endow these cells with differential capacities to take up
and respond to pathogens, this characterization of dendritic
cell subsets is of biological relevance.29 We were also able to
distinguish between immature and mature DCs for the first
time by using DC-LAMP.18 Additionally, we compared these
markers with the well-established markers for leukocytes in
general (CD45) and for dendritic cells in particular (CD11c).
Langerhans Cells
Interestingly, we found corneal Langerin/MHC class II LCs,
especially in the limbal and peripheral epithelium and in the
paracentral region of fresh corneas. Similarly, LCs coexpressing
FIGURE 7. DC-SIGN–stained human corneas. (A) Fresh double-stained cornea immunolabeled for DCs. DC-SIGN (red) and HLA-DR (green). DCs
are located in the stroma (arrows). Most of them were seen in the periphery; few were near the center (B). Double staining with HLA-DR shows
that only some DCs express both markers. (B) Cultured cornea (285 days) stained with the same markers (arrows). (C) Human skin as positive
control. Here DCs are only located in the dermis (arrows). Magnifications, 630 (A, C), 400 (B).
FIGURE 8. DC-LAMP–stained human corneas. (A) Fresh double-stained cornea with markers for DC-LAMP (red) and HLA-DR (green). Mature DCs
are located in the peripheral stroma (arrows) and show expression of both markers. (B) Cultured cornea (7 days) stained with the same markers
(arrows). In human skin (C), mature DCs are located primarily in the dermis (arrows). Magnifications, 630 (B), 400 (A, C).
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CD1a and MHC class II in fresh corneas were also located in the
peripheral and paracentral regions, as were Langerin cells.
Langerin and CD1a cells were not detectable in the centers
of the corneas. Double-labeling experiments revealed that
most, if not all, LCs coexpressed Langerin and CD1a, similar to
the epidermis of skin.17,28 In the skin, Langerin/MHC class II
and CD1a/MHC class II cells (LCs) were found only in the
epidermis,17,28 which is comparable to our observation that
these cells are located almost exclusively in the corneal epi-
thelium. As expected, all Langerin and CD1a cells coex-
pressed CD45, MHC class II, and CD11c.
Corneal LCs have been defined by their epithelial localiza-
tion.1,3,30 CD1a-expressing cells were not detected in earlier
studies using different antibodies and staining techniques.31–34
Expression of CD1a was mainly found in diseased corneas.33
Our observations are in accordance with recent findings of
Yamagami et al.,35 who also found MHC class II epithelial DCs
mainly in the peripheral human cornea. Our observations that
largely immature (DC-LAMP/CD86) MHC class II dendriti-
cally shaped leukocytes in the peripheral cornea express Lan-
gerin and CD1a strongly support the notion that they are LCs.
It remains to be determined to what extent Birbeck granules
are present at the ultrastructural level.
Interstitial Dendritic Cells
This is the first description of interstitial DCs, distinct from LCs,
in the cornea. They were characterized by their DC-SIGN
expression and were located primarily in the peripheral and
paracentral regions and even toward the central anterior
stroma. We also found that few DC-SIGN cells coexpressed
HLA-DR, in contrast to DC-SIGN cells of the human skin.17
This may be a sign of reduced immune competence. Alterna-
tively, these cells may be progenitor cells that do not yet
express MHC class II, as shown for mouse Langerhans cells.36
In the skin, DC-SIGN/MHC class II cells were exclusively
located in the dermis.17 Geijtenbeek et al.15 found human
cutaneous DC-SIGN DCs that were not mature or terminally
differentiated, and DC-SIGN expression did not increase during
maturation. This raises the possibility that DC-SIGN may be
needed primarily by developing DCs not yet expressing opti-
mal levels of MHC peptide and accessory molecules.16 Alter-
natively, DC-SIGN but MHC class II cells may be macro-
phages, as described recently for macrophages of human
lymph nodes.37
Other Antigen-Presenting Cells in the Cornea
The different combinations of antibodies in double-labeling
experiments revealed two additional populations (or differen-
tiation stages) of corneal DCs. In the epithelium, we found
CD45 cells that were Langerin or CD1a. They were located
primarily in the center of the corneal epithelium, where little
or no MHC class II or DC-LAMP expression was detected.
Location in the epithelium meant that they also lacked
DC-SIGN. Therefore, we conclude that this additional popula-
tion has the phenotype CD45/CD11c/MHC-II/DC-LAMP/
Langerin/CD1a/DC-SIGN (Fig. 4, yellow cells). One could
speculate that these cells might be recently arrived LC progen-
itors that still lack MHC class II and Langerin expression.36
Another additional population (Fig. 4, blue cells) became
evident mainly in the stroma. Numbers of MHC class II and
CD11c cells exceeded markedly the numbers of DC-LAMP
mature DCs. Furthermore, in double-labeling experiments,
these cells also lacked expression of DC-SIGN. From this one
may infer a population with the phenotype CD45/CD11c/
MHC class II/Langerin/CD1a/DC-SIGN. From the obser-
vation that in the peripheral parts of the stroma DC-LAMP but
DC-SIGN cells occurred, one may conclude that some of
these DCs were mature in this anatomic region of the cornea.
We did not further characterize this population.
Finally, we found a CD11c/CD11b population (presum-
ably macrophage lineage) only in the posterior part of the
stroma. This was in accordance with data from the mouse
cornea.2 They were located in the peripheral, paracentral, and
even the central regions (Figs. 3, 4). No such cells were found
in the corneal epithelium. All CD11c/CD11b cells coex-
pressed CD45.
Maturation State of Dendritic Cells
DC-LAMP/CD208 is considered a standard maturation marker
for human DCs, including skin DCs.17,38 It is a stringent and
discriminative marker because immature DCs do not express it
at all, whereas they often express low levels of costimulatory
molecules such as CD80 and CD86.17,38 Moreover, DC-LAMP
expression is better suited to determine the state of maturation
by immunofluorescence on tissue sections than by assessing
the different levels in MHC class II expression levels between
immature (low levels; mainly intracellular) and mature (high
levels; mainly cell surface bound) DCs. For the first time, we
could unequivocally discriminate between mature and imma-
ture LCs/DCs.
Overall, we found few mature DCs (DC-LAMP/HLA-DR)
in the fresh peripheral cornea, correlating with observations in
the human skin.17 This applied for the corneal epithelium (i.e.,
for LCs) and for the stroma (i.e., for interstitial/dermal type
DCs). This observation is also consistent with the suggestion of
Hamrah et al.3 that the proinflammatory milieu induced by, for
example, corneal allotransplantation is needed for the matura-
tion of resident immature corneal LCs.3
The virtual absence of DC-LAMP expression in the central
parts of the cornea supports and extends the conclusions of
other reports3 that DCs (CD11c cells in the center of the
cornea) are immunologically immature. In contrast to the mu-
rine cornea,3 however, not all lack MHC class II expression,
though they are devoid of maturation markers such as DC-
LAMP and the costimulatory molecules CD80 and CD86.
Dendritic Cells in Cultured Human Corneas
Few observations refer to the density of LCs/DCs using long-
term cultured human corneas. Most authors have used culture
periods up to 14 days and monitored only HLA-DR expression
of LCs/DCs. Our observations emphasize that DCs and LCs of
the cornea persist longer in culture than had been as-
sumed.10,39–41 Even in the corneas cultured for the longest
periods (1076 days), nearly all epithelial cells were viable. We
found that the densities of LCs and DC-SIGN DCs decreased
with time in culture. Up to 56 days, it was always possible to
verify LCs. Some of them were sporadically found, even after 3
months, which impressively demonstrates the longevity of LCs
and confirms and extends observations from other human42
and murine43 experimental skin models. DC-SIGN cells per-
sist in the cornea even longer than LCs. They were detectable
in corneas cultured up to 3 months and some sporadically up
to 1 year. This observation is important for the allogenicity of
a graft, even after long-term culture. Few DC-SIGN cells of the
long-term cultured corneas were HLA-DR. Mature DCs and
LCs, identified by DC-LAMP, also decreased in cultured cor-
neas, comparable with data from the skin. However, some
were found after more than 60 days. It was interesting that
although the total number of DC-LAMP cells decreased during
culture, some maturation of DCs still occurred for both matu-
ration markers (HLA-DR and DC-LAMP) that peaked at day 56
(Fig. 5B). These results are in accordance with the observations
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from Hamrah et al.,2 who detected mature murine DCs using
costimulatory markers (CD80, CD86). These mature cells
might be functional during an immune reaction.
This is the first documentation of a long-term (more than
200 days) kinetic study of DCs in cornea culture. Given that a
significant decrease of APCs was observed within the first 3
weeks of culture, one could assume that these corneas would
be less immunogenic. This is in agreement with clinical obser-
vations by which increased graft survival was reported, when
corneas were cultured for more than 7 days.10,39–41 Because
some APCs remained for a long time, the graft may still bear a
potential risk for rejection. Most DCs stay in an immature state
and may be capable of antigen uptake and processing. Eventu-
ally, in the inflammatory graft situation, they may mature and
induce rejection.
In summary, our data suggest that culturing corneas for a
certain time span rather than using fresh corneas and manip-
ulating LCs and DCs for maturation and survival may increase
the success rate of corneal transplantation.
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INTRODUCTION
Even though keratoplasty is the most successful 
transplantation of human tissue, corneal graft failure 
is still mainly caused by immunological rejection. 
Therefore, an active reduction of antigen-presenting 
cells (APC) in human corneal graft would be of ben-
efit.
Professional APC do serve as an important link 
between non-specific and specific immune defense 
mechanisms. Immune surveillance and defense are 
critically mediated by these cells, therefore, APC 
migration is essential in corneal immunology.1,2
These cells can lead to graft rejection either via 
the indirect (host APC dependent) pathway or via 
a direct donor APC dependent response (mainly in 
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AbsTRACT
Background: For the fate of a graft the antigen presenting cells play an important role. Chemokines 
can lead to enhanced migration of these cells. We therefore investigated if fresh human corneas 
bear the chemokine receptor 7 (CCR7) and if its ligands can force the emigration of dendritic cells 
in an in vitro model.
Methods: We used human corneas excluded for transplantation and performed migration tests using 
chemokine ligands 19 (CCL19) and 21 (CCL21) or the complement factor 5a (C5a). Emigrated cells 
were collected up to 35 days and stained by immunofluorescent double labeling in triple layer 
technique with Langerin/CD207, DC-SIGN/CD209, CD14, and HLA-DR. In parallel, fresh and 
cultured human corneas were stained for CCR7.
Results: We found in fresh human corneas, as well as in long-term cultured ones, a low CCR7 expres-
sion that nearly diminished after 28 days. In vitro Langerhans cell emigration could be enhanced 
only by CCL19, whereas dendritic cells were strongly influenced by CCL19, CCL21, and C5a. 
HLA-DR+ cells showed numerically the highest in vitro emigration rate. Macrophages/monocytes 
were not influenced by the used chemokines.
Conclusions: Although human corneas reduce their antigen presenting cells numbers during long-
term culture, this effect could be significantly enhanced by using chemokines.
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high risk host beds).3 Huq et al. showed that a donor 
APC-dependent direct response is induced in corneal 
transplant hosts when the graft bed is inflamed, which 
determines the relevance of the graft microenviron-
ment in controlling the pathway of allosensitization.3
Human corneal APC were thought to reside exclu-
sively in the peripheral cornea.4 Recent data of our 
study group confirmed that the whole human cornea 
is endowed with a characteristic population of antigen-
presenting cells including Langerhans cells (LC) or 
other dendritic cells (DC), as shown by other authors 
mainly in the murine model.5–8 We confirmed these 
data in human cornea using novel cell markers, such 
as Langerin/CD207 or DC-SIGN/CD209.9
Mature APC are highly capable of stimulating 
naive T-cells directly in the draining lymph nodes to 
cause an immune reaction.10 Several chemokines are 
involved in APC trafficking to lymphatic tissue. Sub-
stances, such as the chemokine receptor 7 (CCR7) and 
its ligands CCL19 (macrophage inflammatory protein 
3-beta, MIP-3-beta) or CCL21 (secondary lymphoid 
tissue chemokine, SLC), are involved in this process. 
Both chemokines are expressed in T-cell zones of 
secondary lymphoid organs.11–14 By an inflammatory 
stimulus, DC are able to leave peripheral tissues. At 
this point, DC begin to mature and the expression 
of CCR7 increases,15,16 which allows the DC to enter 
lymph vessels and to migrate to T cell areas in draining 
lymph nodes.17 It was shown that a deficiency of CCR7 
or its ligands, CCL19 and CCL21, affects DC migration 
into draining lymph nodes and abnormal lymph node 
function in peripheral tissues appears, suggesting that 
active blocking of CCR7 and CCL21 could potentially 
offer one such venue for inhibiting the induction of T 
cell-mediated immunity,11,18
However, neither the expression of CCR7 in 
human corneas nor the influence of this receptor and 
its ligands in human corneal APC migration has yet 
been investigated. Thus, the aim of this study was to 
investigate the presence of CCR7 on human corneal 
APC in fresh and cultured grafts and to observe the 
influence of various chemokines specific for CCR7 on 
APC behavior in an in vitro model.
MATERIAL AND METHODs
Human Donor Corneas—Preparation and 
Organ Culture
This study was conducted in accordance with the 
Declaration of Helsinki. Human bulbi were primarily 
enucleated for transplantation purposes. For transplan-
tation, excluded corneas were used in our study, which 
were, for example, seropositive for infectious diseases 
or had a low endothelial cell count. Enucleated bulbi 
were dissected under the guidelines for Austrian eye 
banks. In total, 52 corneas of 26 donors were available, 
16 from male and 10 from female donors, ranging in 
age from 49 to 86 years (median of 69 years).
Preparation was performed under sterile condi-
tions as recently described.9 In brief, dissected bulbi 
were washed for 5 min with floating tap water, decon-
taminated with povidone iodine (Polyvidon-Jod 0.5%; 
Betaisodona; Mundipharma, Limburg/Lahn, Ger-
many). Bulbi were then trepanned (diameter of 14 mm) 
and then the limbal and scleral parts were removed 
using small scissors resulting in a final size of 10 to 
11 mm of each cornea. Then the isolated corneas were 
washed with phosphate buffered saline (PBS).
In Vitro Emigration Assay
Corneas were placed in pairs into a sterile 12-well-plate 
(Falcon, Becton Dickinson Labware, Franklin Lakes, NJ, 
USA), each cornea in a separate well. One cornea was 
used for the emigration test, the other one served as a 
negative control. Each well contained 3 ml of organ cul-
ture medium (RPMI 1640 with 2.0 g/L NaHCO3, with-
out phenol-red and without L-glutamine; Biochrome, 
Berlin, Germany) supplemented with a mixture of 
100 U/mL penicillin G, 100 μg/mL streptomycin, 
0.25 μg/mL amphotericin B (Gibco/Invitrogen, 
Grand Island, NY, USA), 2 mM L-glutamine (low 
endotoxine; Biochrome, Berlin, Germany), 25 mM 
HEPES-buffer (Biochrome, Berlin, Germany), and 5% 
fetal calf serum (Gibco/Invitrogen). The incubation 
for the test series was performed at 37°C. The follow-
ing chemotactical substances were used: recombinant 
human CCL19 (at a working concentration of 25 ng/
ml), CCL21 (50 ng/ml), both from Peprotech, Rocky 
Hill, NJ, USA; and recombinant human C5a (5 ng/ml) 
from R&D Systems, Minneapolis, Minneapolis, USA.
On days 3, 7, 10, 14, 21, 28, and 35 the cornea pairs 
were placed into the next well under sterile conditions 
containing fresh culture medium with or without 
stimulating chemokines.
In addition, emigrated APC were collected. The non-
adherent (dendritic) cells were isolated and resuspended 
in 1 ml PBS (Biochrome), while the adherent cells (mac-
rophages/monocytes) were collected by washing the 
wells with cold PBS and trypsin/EDTA (0.05/0.02% 
trypsin/EDTA in HBSS, PAN-Biotech GmbH, Aiden-
bach, Germany). After a short period of cold incuba-
tion, the cells were manually scraped with a plastic cell 
scraper (Sarstedt, Newton, North Carolina, USA). The 
suspensions of the nonadherent and the adherent cells 
were spun down at 250 g (1200 rpm, Hettich, Rotanta, 
TRC) for 10 min and filtered through a 70 μm cell strainer 
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(Falcon, Becton Dickinson, Bedford,  Massachusetts, 
USA) to separate the APCs from cell detritus.
Cytospins of these cells were performed 
(220 g/1100 rpm for 10 min and then 1500 g/3000 rpm 
for 1 min, Hettich, Rotanta, TRC). Cells were then put 
onto slides (Superfrost Plus, Menzel Braunschweig, 
Germany). Cells on slides were fixed for 10 min in pure 
aceton (Scharlau Chemie, Barcelona, Spain) at room 
temperature and stored at -20°C until staining.
Cytospin-slides were stained by immunofluorescent 
double labeling in triple-layer technique with different 
antibodies listed and described below.
Stained cells were counted with an optical micro-
scope (DMLB, Leica, Leica Systems, Wetzlar, Germany) 
using a software-controlled scanning grid (PicED Cora; 
Jomesa Messsysteme GmbH, Munich, Germany). 
Each slide was completely inspected using magnifica-
tions of ×100 and ×400 and the numbers of cells were 
 averaged.
Student’s t-test was used to compare the number of 
positively labeled migrated antigen presenting cells of 
the epithelium and stroma of cultured corneas. P < 0.05 
was considered as statistically significant.
CCR7
To investigate if CCR7-positive cells can be found in 
human corneas, we prepared cryosections from fresh 
(not cultured) corneas, as well as from cultured corneas 
(up to 28 days) using a microtome (CR-3050, Leica-
Microsystems, Wetzlar, Germany). Deep frozen tissue 
was embedded in optimum cutting temperature (OCT) 
compound medium (Tissue-Tek, Sanova, Vienna, Aus-
tria). Human skin and human tonsil samples served 
as positive controls. Sections were cut into 8 μm thin 
sheets at -26°C, allowed to dry at room temperature for 
1 hr, and stored at -20°C until staining.
Antibodies
The following unconjugated primary mouse antibod-
ies were used at the indicated final concentrations: 
anti–CD207/Langerin (clone DCGM4, IgG1, 4 μg/mL; 
Beckman Coulter, Fullerton, CA, USA), anti–CD209/
DC-SIGN (clone DCN46, IgG2b, 5 μg/mL; BD Biosci-
ences, San Diego, CA, USA), anti-CD14 (clone M5E2, 
IgG2a, 5 μg/mL; BD Biosciences), and hCCR-7 (clone 
150503, IgG2a, 15 μg/mL; R&D Systems, Minneapolis, 
MN, USA). As there is only low-level expression of 
CCR7 on LC and DC in the normal human cornea, we 
used tyramide amplification to boost the visualization 
of staining, according to the manufacturer’s instructions 
(PerkinElmer Life Sciences, Boston, Massachusetts).
A FITC-conjugated anti-HLA-DR antibody mouse 
antibody FITC-anti–HLA-DR (clone L243, IgG2a, 
2.5 μg/mL; BD Biosciences, Franklin Lakes, NY, USA) 
was used in immunofluorescent double-staining 
experiments.
Used isotype specific negative controls were as fol-
lows: mouse IgG1 (clone DAK G01, DAKO, Glostrup, 
Denmark), mouse IgG2b (clone DAK G09, DAKO), 
mouse IgG2a (DAK G05, DAKO) and FITC-conju-
gated mouse IgG2a (clone RPC 5, Hölzel Diagnostika, 
Cologne, Germany).
Immunofluorescent Double Labeling in  
Triple-Layer Technique
Staining procedures were performed as recently 
described.9 Briefly, cells on slides were first incubated 
with primary unconjugated antibodies (all diluted in 
PBS/1% bovine serum albumin for 30 min at 37°C). 
After 5 min of washing in PBS/1% BSA, the biotiny-
lated secondary antibody (sheep anti-mouse immu-
noglobulin, dilution 1:100; Amersham Pharmacia 
Biotech, Buckinghamshire, UK) was applied for 30 min 
at 37°C. Afterwards, the slides were incubated with 
Texas Red-conjugated streptavidin (Amersham Phar-
macia Biotech, Buckinghamshire, UK; dilution 1:100, 
for 30 min at 37°C). Then a mouse gamma-globulin 
blocking reagent at a final concentration of 100 μg/mL 
(Jackson ImmunoResearch Laboratories, West Grove, 
PA, USA) was used to avoid binding of the subsequent 
FITC-conjugated antibody to residual free binding sites 
of the preceding anti-mouse immunoglobulin anti-
body. Finally, the FITC-conjugated mouse anti-human 
HLA-DR antibody was incubated for 30 min at 37°C 
and the tissue sections were covered with fluorescent 
mounting medium (Vectashield; Vector Laboratories, 
Burlingame, California, USA).
REsULTs
Expression of CCR7
Important for all experiments was to know if fresh 
human corneal APC always express CCR7, as CCL19 
and CCL21 are ligands to this receptor. We found that 
CCR7 in the fresh (non-cultured) human cornea was 
only expressed to a slight amount. We, therefore, used 
the tyramid signal amplification system (TSA-System, 
PerkinElmer Inc., Newton, New Jersey, USA) to boost 
the immunofluorescent signal. A human palatine tonsil 
and human skin were used as positive controls. In the 
human skin, CCR7+ cells were seen in the basal cell 
layer of the epidermis and the dermis (Figure 1B).
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Generally, CCR7 positive cells were only found to 
a slight amount. Most CCR7+ cells were observed in 
fresh human corneas, located mainly in the periph-
eral and limbal regions of the epithelium and the 
anterior stroma (Figure 1A). During the first days 
of organ culture, the number of CCR7 positive cells 
strongly decreased. On day 14, we observed a rela-
tive increase to about the half of the CCR7+ cells of 
a fresh cornea. Then again these cells decreased and 
after 28 days of culture they nearly disappeared 
(Figure 1C).
Enhanced In Vitro Migration of APC Using 
 Different Chemokines
In this study we investigated the evasion of APC (LC, 
DC, macrophages, and HLA-DR+ cells) of human 
corneas during organ culture without any stimulus 
and compared this to the recruitment effect of vari-
ous chemokines. Comparable to fresh human corneas 
also all migrated LC expressed Langerin and HLA-DR 
(Figure 1D), whereas not all DC expressed HLA-DR in 
double staining experiments (Figure 1E).
We sometimes observed a loss of APC by a partial 
ablation of the corneal epithelium in the first days of 
organ culture, following agglutination of corneal epi-
thelium, which implicated cell-death (loss of APC). 
This cell loss happened possibly because of the obliga-
tory decontamination step when preparing the corneas. 
It is known that the surface will be covered by new 
epithelium within a few days of organ culture. But for 
our studies, if epithelial ablation was encountered in 
cytospin specimens (spot of high density) results were 
not included in the evalutation.
In Vitro Migration of Langerhans Cells
Addition of CCL19 increased the in vitro migration 
of Langerin+ LC up to six-fold in all of the examined 
corneas. First effect was already seen after 4 days of 
organ culture, and a maximum of the migration peak 
was achieved between days 4 and 7. The enhanced in 
vitro emigration was statistically significant (p < 0.05) 
during the first two weeks compared to the negative 
controls (Figure 2). No effect was seen using CCL21 or 
the anaphylatoxin C5a (data not shown).
In Vitro Migration of Dendritic Cells
The chemokine CCL19 lead to a two- to six-fold 
increased in vitro migration during the first 21 days in 
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FIGURE 1 Immunofluorescent staining of LC/DC. (A) 
CCR7+ cell of the fresh human cornea. Note that this cell is 
located subepithelially in the peripheral area. Magnifica-
tion, ×400. (B) CCR7+ cells in human skin as positive control. 
These cells are located between dermis and epidermis (dot-
ted line). Magnification, ×400. (C) Alteration of CCR7+ cells 
during organ culture (cells/mm2;). Although in total very 
few, most CCR7+ cells were found in fresh corneas, following 
a decrease during long-term culture. On day 14, a relative 
increase was observed and nearly diminished on day 28 
of culture. (D) In vitro emigrated LC from corneas cultured 
for 10 days (Cytospin). Langerin+ (red)/HLA-DR+ (green) 
emigrated LC surrounded by epithelial cells. Magnification, 
×400. (E) In vitro emigrated DC from corneas cultured for 
7 days (Cytospin). The left cell shows only DC-SIGN+ (red) 
staining, whereas the right cell is also HLA-DR+ (yellow). 
Magnification, ×400.
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FIGURE 2 Influence on in vitro LC (Langerin+/HLA-DR+) 
migration using CCL19. This chemokine, in a concentration 
of 25 ng/ml (□), leads to a statistically significant (*) in vitro 
migration of LC up to 14 days compared to the negative 
controls (◆); n = 6. Error bars indicate the mean and standard 
devation (SD) of the experiments.
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all observed corneas. On day 14, we found the highest 
in vitro migration of DC-SIGN+ DC which was six-fold 
higher compared to the negative controls (Figure 3A). 
The difference of active in vitro migration using CCL19 
during the first three weeks was statistically significant 
(p < 0.05).
Using CCL21 we also saw an enhancement of 
in vitro migrating cells during the first two weeks, 
which was in the range of two- to five-fold compared 
to the negative controls without a chemotactic stimulus 
(Figure 3B). The difference was statistically significant 
during the first two weeks (p < 0.05).
Using the anaphylatoxin C5a we also could enhance 
the in vitro migration of DC out of the cornea but not 
more than two-fold. During 21 days of observation 
the chemokine-driven in vitro emigration was statis-
tically significant (p < 0.05) compared to the negative 
controls (Figure 3C). The numbers of emigrated cells 
were lower as compared to cultures containing CCL19 
and CCL21.
In Vitro Migration of Macrophages/Monocytes
None of the used attracting factors could influence 
the in vitro migration of macrophages/monocytes 
(CD14+/HLA-DR+ cells) at any time of cell harvest-
ing. In general we only saw small numbers of in vitro 
migrating CD14+ cells during the whole observation 
period (data not shown).
In Vitro Migration of HLA-DR+ Cells
We stained all into the culture medium emigrated 
cells not only for Langerin or DC-SIGN but also for 
HLA-DR to indicate the activated/mature status of the 
APC. Whereas all LC expressed HLA-DR, only some 
of the DC-SIGN+ cells and not all of the macrophages/
monocytes (CD14+) did express HLA-DR. But there 
were even other cells, e.g., CD11c+, CD11b+, or CD45+, 
etc., which bear HLA-DR on their cell surface. This 
was already shown in a previous work and by other 
authors.2,9
Stimulation with CCL19 led to a strong peak of 
in vitro emigrating HLA-DR+ cells on day 7 (more 
than three-fold) and was still more than two-fold 
on day 10 (Figure 4A). The difference of chemokine-
driven in vitro emigration compared to the negative 
controls was statistically significant at these days 
(p < 0.05).
Using CCL21 the enhanced in vitro migration was 
in a two- to three-fold range compared to the non-
stimulated corneas and was observed from days 3 to 
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FIGURE 3 Influence on in vitro DC (DC-SIGN+) migration using different chemokines (□). (A) CCL19 (25 ng/ml) n = 6; (B) CCL21 
(50 ng/ml) n = 8; (C) C5a (5 ng/ml) n = 6. Note that there was a statistically significant difference (p < 0.05) observed on the marked 
days (*) compared to the negative controls (◆).
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14 (Figure 4B). This was statistically significant from 7 
to 21 days (p < 0.05).
Also C5a led to a strong enhancement of in vitro 
emigrating cells, which was statistically significant 
already from 3 to 10 days (p < 0.05). A maximum up 
to a three-fold rate was reached with this chemokine 
(Figure 4C).
DIsCUssION
The fate of a graft is dependent on one mainly part 
by the immune competent APC. Although a diminu-
tion in organ culture of these cells was observed,9,19,20 
it would be of benefit to actively reduce these cells. In 
a long-term follow up of cultured human corneas we 
found a markedly loss of APC during the first three 
weeks of culture.9 Küchle et al. showed in a clinical 
study that corneal organ culture leads to a reduced 
risk for immune reactions after performing penetrating 
keratoplasty.21 It is known that DC can be attracted by 
chemokines and that chemokine receptor 7 plays an 
important role in mediating APC trafficking.11,22,23 Jin 
et al. showed in a mouse model that murine corneal 
APC expressing CCR7 interact with CCL21 to facilitate 
DC migration to the lymph nodes.18 They found CCR7 
expression only in inflamed murine corneas.
In contrast to this, our findings—performed in 
human corneas—showed that CCR7 could be observed 
even in non-inflamed corneas. We detected this recep-
tor at a low expression level not only on in vitro emi-
grated cells but also in fresh human corneas in the 
sub-epithelial and stromal areas where LC or DC are 
residing. Although in a low number, CCR7+ cells were 
mainly found in fresh corneas. During organ culture, 
the amount of these cells strongly decreased. Interest-
ingly, we observed a relative increase on day 14, pos-
sibly due to the influence of organ culture medium, 
i.e., fetal calf serum. From other human tissues, such 
as skin or tonsils, it is known that CCR7 is expressed 
at low level also without stimulation,13 suggesting that 
CCR7 may not be the exclusive mediator of DC migra-
tion from the cornea to lymphoid tissues.
Chemo-attractant substances, such as CCL19 and 
CCL21, are the ligands for this receptor and lead to an 
emigration of DC and trafficking into lymph nodes. 
Using CCL19 and CCL21 we could indeed detect 
a significant difference in active in vitro migration 
of DC.
Jin et al. obtained similar results in a corneal mouse 
model.18 Interestingly, we also found a significant 
increase of in vitro cell migration with CCL19 in LC, 
which was not reported for the mouse cornea. Analo-
gous observations were already made in skin.24
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FIGURE 4 Enhancement of in vitro migrating HLA-DR+ cells using different chemokines (□). (A) CCL19 (25 ng/ml) n = 12; (B) 
CCL21 (50 ng/ml) n = 18; and (C) C5a (5 ng/ml) n = 18. Note that there was a statistically significant difference (p < 0.05) seen 
on the marked days (*) compared to the negative controls (◆).
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Additionally, we found that CCL19 and CCL21 
could not influence the in vitro migration of CD14+ cells 
(i.e., macrophages/monocytes) in human corneas.
C5a is an anaphylatoxin that regulates chemotaxis 
and activation of neutrophils, eosinophils, basophils, 
and monocytes. Another important function of this 
complement factor is directing skin DC into lymphatic 
tissue. 25,26 In skin, only 5–10% of LC do express the 
C5a receptor (CD88) in contrast to dermal DC.27 This 
is in accordance with our results that C5a could not 
stimulate Langerin+ LC for in vitro migration, but could 
stimulate DC-SIGN+ DC. Soederholm et al. found that 
C5a mediates cell recruitment mainly of immature DC 
(i.e., HLA-DR−).28 This is in accordance with our obser-
vations that most of the DC-SIGN+ DC were HLA-DR.
Comparing the rate of in vitro cell migration using 
the three different chemokines we found the highest 
amount in the HLA-DR+ cells, because this cell surface 
molecule is not only expressed on LC or DC but also on 
a wide range of APC. It is well known that the human 
cornea harbors a heterogeneous population of bone 
marrow derived cells which express the leukocyte 
common antigen, CD45.2,6 We confirmed in our previ-
ous study that HLA-DR+ APC are CD45+.9
Interestingly, we found emigrated cells over the 
entire observation period of 35 days, whereas Ardjo-
mand et al. detected HLA-DR+ cells up to 14 days.19 
It must be considered that in our in vitro cornea 
model the organ culture medium (i.e., the used fetal 
calf serum) may have an effect on APC maturation/
activation19 and their recruitment, which is possibly 
associated with a stronger expression of different cell 
surface receptors such as the CCR7.
The number of in vitro migrated cells was lower than 
expected compared to previous results of our study 
group, where we investigated various APC in the human 
cornea during organ culture.9 One possible reason could 
be the obligatory chemical decontamination step that 
often leads to a detachment of corneal epithelium with 
a loss of epithelial APC, but this would explain only a 
diminution of LC in the epithelium and not of stromal 
DC. Therefore, either a down-regulation of receptors 
or cell death during the culture could happen. The cell 
loss associated with mechanical collection at the various 
time points of observation may be another good reason 
why only few cells compared to previous findings in 
whole corneal flat mounts were seen.
There is no doubt that APC play a critical role in 
graft rejection. Ourselves and other have shown earlier 
that a long-term culture of human corneas leads to a 
decrease of residing APC. Nevertheless, it would be 
desirable to deplete or at least actively reduce these 
immunocompetent cells.
This study is meant to deliver another step for the 
understanding of immunological processes in the cor-
nea. It is the first study which shows that in human 
corneas some APC bear receptors such as CCR7 suit-
able for the use of chemokine ligands like CCL19 or 
CCL21 as possible tools to significantly enhance the 
in vitro migration of APC out of the corneas.
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